Abstract:AIM: To clone and characterize novel genes that might be involved in hepatocellular carcinoma. METHODS: An EST fragment differentially expressed between hepatocellular carcinoma (HCC) and its adjacent nontumorous liver tissues had been doned using suppression subtractive hybridization (SSH). With this approach, we identified a novel EST that consisted of 447bp. In order to gain its full-length cDNA fragment, two gene-specific primers were designed for 3′-rapid amplification of cDNA end RACE. One HCC cell line, HepG2, was maintained in the RPMI1640 media and recommended culture conditions. Total RNA was extracted from HepG2 by the SV Total RNA Isolation System (Promega). PACE reactions were prepared using the SMART™ RACE cDNA amplification kit (Clontech). Initial amplification was carried out with gene-specific primer 3′GSP2(5′-CGCATAGT ACCAGTATCGACAA AGG-3′), followed by nested PCR using gene-specific primer 3′NGSP2(5′-TCCACATTACGGACCCGACGGATT- 3′). These amplified cDNA fragments obtained from RACE were subcloned into the PMD18-T vector (TaKaRa) and sequenced by ABI PRISM377 DNA sequencer. Basic local aligment search tools were carried out using BLASTN and dbEST and nr database. Northern blot was applied to detect the expression of these cDNA fragments between HCC and its adjacent nontumorous liver tissues. A total of 3 liver specimens were collected from the Southwest Hospital of Chongqing in China. The final diagnosis of HCC was confirmed by histological examination. Total RNA was extracted from either HCC or its adjacent nontumorous liver tissues in the same way. These cDNA fragments were excised from the PMD18-T vector, purified and 32P-labeled as cDNA probes using the random primed labeling method. Northern blot was prepared by using the ExpressHyb™ hybridization solution (Clontech) according to the protocol provided by the manufacturer. Combination of Northern blot and virtual Northern (http://www.ncbi.nlm.nih.gov/SAGE) (series analysis of gene expression, SAGE), expression of these cDNA fragments in multiple carcinoma and normal tissues were analyzed. RESULTS: Five EST fragments (694 447-3, 724 447-3, 697 447-3, 711 447-3, 692 447-3) were cloned, including two EST fragments with ploy (A) tail (694 447-3, 724 447-3). Compared with ESTs in GeneBank, the two EST fragments with ploy (A) tail represented novel genes with a common sequence. Five EST fragments accession numbers in Genebank were CK730344, CK730345, CK730346, CK730347, CK730348, respectively. Northern blot revealed that 694 447-3, 724 447-3 presented higher expression in HCC than that in its adjacent nontumorous liver tissues. Virtual Northern blot (SAGE) revealed that 694 447-3, 724 447-3 presented higher expression in multiple cancers that contained in brain, colon, breast, lung and stomach than that in their normal tissues. CONCLUSION: Two novel human hepatocellular carcinoma-associated cDNA fragments are identified. RACE technique is a rapid and effective method for seeking for disease related genes in specific tissues.

Screening and Analysis of Differentially Expressed Genes in Human Hepatocellular Carcinoma Using Suppression Subtractive Hybridization

Identification Of Genes Differentially Expressed In Human Hepatocellular Carcinoma By A Modified Suppression Subtractive Hybridization Method

Construction of a Subtracted Cdna Library of Differentially Expressed Genes in Human Normal Liver Tissue and Primary Hepatocellular Carcinoma Tissue

Identification of the typical miRNAs and target genes in hepatocellular carcinoma.

Genes Encoding Pir51, Beclin 1, RbAp48 and Aldolase B Are Up or Down-Regulated in Human Primary Hepatocellular Carcinoma.

Construction and Screening of Suppression Subtractive Hybridization Library of Human Primary Hepatocellular Carcinoma

Rapid cloning and expression of hepatocellular carcinoma associated cDNA fragments

Screening of Novel Hepatocellular Carcinoma-Associated Genes

High-throughput sequencing-based analysis of gene expression of hepatitis B virus infection-associated human hepatocellular carcinoma

Screening of Differentially Expressed Genes in Human Renal Cell Carcinoma Using Suppression Subtractive Hybridization

Genes Expression Profiling of Peripheral Blood Cells of Patients with Hepatocellular Carcinoma

Expression Profile Reveals Novel Prognostic Biomarkers in Hepatocellular Carcinoma.

[Differentially Expressed Genes in Hepatocellular Carcinoma of Tree Shrew Induced by Different Factors].

Profiling and Integrated Analysis of Differentially Expressed MicroRNAs as Novel Biomarkers of Hepatocellular Carcinoma

Insight into Hepatocellular Carcinogenesis at Transcriptome Level by Comparing Gene Expression Profiles of Hepatocellular Carcinoma with Those of Corresponding Noncancerous Liver

Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis

[Molecular Cloning of Genes Differentially Expressed in Human Lung Squamous Cell Carcinoma Using Suppression Subtractive Hybridization].

Identification of Hepatocellular Carcinoma-associated Hub Genes and Pathways by Integrated Microarray Analysis

Differentially expressed genes in hepatocelullar carcinoma and non-tumor tissue of mouse induced by woodchuck hepatitis B virus

Screening of Tumor Metastasis Related Differentially Expressed Genes in Hepatocellular Carcinoma Cells with FATE/BJ-HCC-2 Gene Stable Transfection by Gene Chip

Discovery and Analysis of Hepatocellular Carcinoma Genes Using Cdna Microarrays